Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Coherent Market Insights
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Drugs, Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)) - Insights, Opportunity Analysis, and Industry Forecast till 2024

Published Date : May 2017

Contraceptive Drugs and Devices – Choice to Conceive, Not Concede As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years

Coherent Market Insights
Global Erectile Dysfunction Market, By Product (Viagra (Sildenafil citrate), Cialis (Tadalafil), Stendra/Spedra, Levitra/Staxyn, Zydena (Udenafil), Vitaros (Alprostadil Cream)), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024

Published Date : Apr 2017

Erectile Dysfunction: A Prominent Age Related Disorder Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient

Coherent Market Insights
Global Tuberculosis Drugs Market, By Therapy Type (First Line Drugs Therapy, Second Line Drugs Therapy, Combination Drugs Therapy), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024

Published Date : Mar 2017

Tuberculosis Drugs: Hopes Pinned on Renewed Government Investments in Emerging Economies Tuberculosis is a chronic condition that is often undermined, though it can be fatal if left unchecked. Thankfully, ext

Coherent Market Insights
Global Prefilled Syringes Market, By Drug Type (Biologics, Vaccines, Insulin), Material (Glass, Plastic & Polymer), and Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Aug 2017

Prefilled Syringes- Insights into Novel Drug Delivery System The prefilled syringes are one of the fastest growing choices for the unit dose delivery and has emerged as one of the most convenient way of drug

Coherent Market Insights
Global Precision Medicine Market, By Technology (Bioinformatics, Gene Sequencing, Drug Discovery, Precision Molecular, Diagnostics, Big Data Analytics), Application (Oncology, CNS, Hematology, Respiratory, Immunology), and Geography - Insights, Size, Share, Opportunity Analysis, & Industry Forecast till 2025

Published Date : Sep 2017

Precision Medicine Market – Not one-size fits all Precision medicine is an emerging field, which tailors the treatment according to the individual’s genetic makeup, lifestyle, and environment. Th

Coherent Market Insights
Global Opioids Agonist Drugs Market, By Product Type (Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone), Therapeutic Application (Pain Management, Cough Treatment, Diarrhea Treatment), and Geography - Trends, Analysis and Forecast till 2024

Published Date : Mar 2017

Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth Opioids are generally prescribed for treating pain. The opioid drug class includes morphine, hydrocodone, oxycodone, heroin, codeine, morphine

Coherent Market Insights
Global Smoking Cessation and Nicotine De-addiction Products Market, By Product Type (Nicotine Replacement Therapy, Drugs, E-Cigarettes), Distribution Channel (Hospital Pharmacies, Online Channel, Retail Pharmacies), Geography - Trends, Analysis, and Forecast till 2024

Published Date : Mar 2017

Are E-cigarettes the E-asy Way Out of Smoking? Cigarette packs have been mandatorily carrying a warning stating ‘Smoking is injurious to Health’, while some countries have resorted to even more gr

Coherent Market Insights
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Toxoid Vaccines, Live Attenuated Vaccines, Subunit and DNA Vaccines, Conjugated Vaccines), Animal Type (Companion Animal, Livestock Animal), and Geography - Trends, Analysis, and Forecast till 2024

Published Date : Feb 2017

Veterinary/Animal Vaccines – Ensure good health of human’s best friends Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccin

Coherent Market Insights
Global Pharmaceutical Excipients Market, By Chemistry (Plants, Animals, Minerals, Synthetic Source), Functionality (Binders, Diluents, Glidents, Disintegrants), Application (Oral, Parenteral, Topical), and Geography - Trends, Analysis and Forecast till 2024

Published Date : Feb 2017

Pharmaceutical Excipients – Paving the way for Low-cost Pharmaceuticals Pharmaceutical excipients are crucial contents of a formulation that enable effective drug absorption. Excipients must suit the in

Coherent Market Insights
Global Malaria Vaccines Market, By Vaccines Type (Pre-Erythrocytic Vaccine, Erythrocytic Vaccine, Multi-antigen Vaccine), Agent (Plasmodium Falciparum, Plasmodium Vivax), Distribution Channel (Hospitals, Clinics, Community Centers), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024

Published Date : Apr 2017

Malaria Vaccines – Paving the Way for a Malaria-free World Nearly half of the global population is at risk of malaria as per stats released by the World Health Organization (WHO). This in turn has led t

Coherent Market Insights
Global Anti-Suicide Drugs Market, By Chemistry Type (Anti-Depressants and Anti-Anxiety Drugs, Anti-Psychotic Drugs, NMDA Antagonist, Antibiotic Analog), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024

Published Date : Mar 2017

Anti-Suicide Drugs – Beacon Light of Life on the Horizon Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Ant

Coherent Market Insights
Fibrosarcoma Drugs Market by Type (Adult Fibrosarcoma and Infantile Fibrosarcoma) by Active Ingredient (Doxorubicin Hydrocholride, Ifosfamide, Dacarbazine, Pazopanib Hydrochloride, and Other Active Ingredient) by Route of Administration (Oral and Injectable) by Distribution Channel (Hospital Pharmacies and Retail Pharmacies) - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2017- 2025

To Be Published : May 2018

Fibrosarcoma is a rare type of soft tissue malignant tumour composed solely of fibre-forming connective tissue called as fibroblasts. Although, this condition can occur at any age, it is commonly diagnosed between the age of 30-60 years. Patients suffering from geneti

Coherent Market Insights
Clostridium Difficile Infection Treatment Market - by Drug Class (Metronidazole, Fidoxamycin, Vancomycin, and Other Drug Class), by Route of Administration (Oral and Intravenous/Parenteral), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Clostridium difficile, which produces gram-positive bacterium, is an anaerobic toxin that gets transmitted through fecal-oral route. Clostridium difficile infection occurs during antibiotic treatment or can be caused due to healthcare associated infection with clinica

Coherent Market Insights
Osteonecrosis Treatment Market - By Drug Class (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Anti-Coagulant, and Other Drugs) and By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Osteonecrosis is a disease in which bone cells dies or bones collapse due to lack of blood flow to the bones. It is also known as avascular necrosis, aseptic necrosis or ischemic necrosis. Osteonecrosis is most commonly developed in hip bone (femur) or knees, while le

Coherent Market Insights
Thrombocytopenia Treatment Market, By Drug Class (Glucocorticoids, Lysosomal Enzyme, and Platelet Stimulating Agent), and By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

Thrombocytopenia is a disorder in which a patient has low level of platelets in the blood. The major causes of thrombocytopenia are inefficient production of platelets, platelet splenic sequestration, and accelerative destruction of platelets. The most common ineffect

Coherent Market Insights
Stroke Management Market, by Product Type (Diagnostic, Drug Therapy Products and Interventional Stroke Management Systems), by Application Ischemic Stroke and Hemorrhagic Stroke), and by End User (Hospitals, Clinics, Retail Pharmacies, Ambulatory Surgical Centers, Diagnostic Laboratories, Online Pharmacies, and Other End Users) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 – 2025

To Be Published : May 2018

Stroke is a medical condition in which blood clot blocks the blood vessels and interrupts the blood flow to the brain, resulting in cell death. Under the guidelines of American Stroke Association, there are of 3 types of strokes: ischemic stroke (an obstruction within

Coherent Market Insights
Huntington’s Disease Treatment Market, By Drug Type (Tetrabenazine, Deutetrabenazine, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2017–2025

To Be Published : May 2018

Huntington's disease, also known as Huntington's chorea, is an autosomal dominant inherited rare disorder that causes progressive degeneration of nerve cell of brain leading to deterioration of a person’s physical and mental abilities. Huntington's disease sympt

Coherent Market Insights
Over-the-Counter Drugs Market - Global Competitive Analysis

To Be Published : May 2018

Over-the-counter drugs, also known as non-prescription drugs, are available in pharmacies and other retail stores and can be used without being prescribed by a doctor. These drugs are critical components of the pharmaceutical industry as they are highly potent and hav

Coherent Market Insights
Global Oncology Drugs Market - Competitive Analysis

To Be Published : May 2018

Oncology drugs and medications have become a blooming business for players in the pharmaceutical industry. Major pharmaceutical companies are focused on manufacturing and development of oncology drug. Market players have oncology drugs in pipeline, which are expected

Coherent Market Insights
Back Pain Therapy Market, By Drug Type (Non-steroidal Anti-Inflammatory Drugs, Analgesics, Muscle Relaxants, and Others), By Indication (Herniated Disc, Arthritis, Osteoporosis, and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), and By Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Back pain is mainly caused due to muscular strains, strained ligaments, and muscular spasms in any region of the back. Chronic diseases such as herniated discs, arthritis, and osteoporosis can lead to back pain. Depending on the severity of the symptoms, back pain can

Coherent Market Insights
Angioedema Treatment Market, by Condition Type (Allergic Angioedema, Drug-induced Angioedema, Idiopathic Angioedema, and Hereditary Angioedema (HAE)), by Drug Type (C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, and Others), by Route Of Administration (Injection and Oral), by Distribution Channel, and by Geography- Global Industry Insights, Trends, Outlook, And Opportunity Analysis, 2017-2025

To Be Published : May 2018

Angioedema is the medical condition characterized by swelling of the lower layer of skin and tissue just under the skin or mucous membrane occurs. There are four main type of angioedema namely allergic angioedema, drug-induced angioedema, Idiopathic angioedema, and he

Coherent Market Insights
Gouty Arthritis Market, by Drug Class (NSAIDs, Corticosteroids, Colchicine, and Urate-lowering agents), by Gouty Type (Acute Gouty Arthritis and Chronic Gouty Arthritis) and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Gouty arthritis is characterized by intense joint pain due to deposition of uric acid crystals. Symptoms of gouty arthritis include redness and swelling of joints and intense pain. The condition can be treated with the help of medication. Uric acid is deposited either

Coherent Market Insights
High Potency Active Pharmaceutical Ingredients Market, By Synthesis Route (Synthetic and Biotech), By Drug Type (Branded HPAPI and Generic HPAPI), By Manufacturer Type (In-House and Contract Research Manufacturers), and By Therapeutic Applications (Oncology, Hormonal Disorders, Glaucoma, and Others) - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2017-2025

To Be Published : May 2018

High potency active pharmaceutical ingredients (HPAPIs) are small-molecule, biologic, or hybrids of antibody–drug conjugates, which link a cytotoxic small-molecule to a monoclonal antibody. Demand for high potency active pharmaceutical ingredients (HPAPIs) is ra

Coherent Market Insights
Large Volume Parenteral Market by Treatment Type (Fluid Balance Injections, Therapeutic Injections, and Nutritious Injections), by End User (Hospitals, Ambulatory centers, Clinics, and Others) and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 – 2025

To Be Published : May 2018

Parenteral are sterile dosage form that are administered through route other than oral route of administration. They are injected into one or more layer of skin and active ingredient directly come in contact with tissue or blood vessel. Large volume parenteral are of

Coherent Market Insights
Pompe Disease Therapeutic Market, by Therapy Type (Gene Therapy, Enzyme Replacement Therapy (ERT), and Chaperone-Advanced Replacement Therapy (CHART)), by Administrational Route (Oral and Parenteral), and by Patient Type (Infants and Adults) - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2017 - 2025

To Be Published : May 2018

Pompe disease is an inherited Lysosomal Storage Disorder (LSD) caused by a deficiency of enzyme acid named alpha-glucosidase (GAA). This causes the glycogen to accumulate in different kinds of tissues, primarily into smooth muscles, skeletal muscles and cardiac muscle

Coherent Market Insights
Stargardt Disease Therapeutics Market by Treatment Type (Drugs, Gene Therapy, and Stem Cell Therapy), By Stages of Development (Children, and Adult) By Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 - 2025

To Be Published : May 2018

Stargardt disease is an inherited juvenile macular degeneration that causes vision loss. The signs and symptoms of the disease typically appear in late childhood or early adulthood and worsen with time. The most common cause of the disease is mutations in the ABCA4 ge

Coherent Market Insights
Micro-hospitals Market, By Location (Tier-1 Cities, Tier-2 Cities, and Tier-3 Cities), By Area of Occupation (15,000–40,000 Sq. Feet and More than 40,000 Sq. Feet), By End User (Individuals and Corporate), and By Geography — Global Industry Insights, Trends, Outlook, and Opportunity Analysis 2017–2025

To Be Published : May 2018

Micro-hospitals are small scale inpatient facilities with eight to 15 beds and in an area of 15,000 to 60,000 square feet on an average. Micro-hospitals operate in metropolitan area, within range of 20–25 miles of large scale hospitals. They have large operation

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.